title: Cat-scratch-disease-associated macular oedema treated with intravitreal ranibizumab.
authors.affiliation: Ophthalmology Department, State Hospital Feldkirch, Feldkirch, Austria.
authors.forename: Kleanthis
authors.initials: K
authors.lastname: Manousaridis
authors.forename: Silvia
authors.initials: S
authors.lastname: Peter
authors.forename: Stefan
authors.initials: S
authors.lastname: Mennel
mesh_terms: D000328:Adult; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000907:Antibodies, Bacterial / Q000097:blood; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D018416:Bartonella henselae / Q000276:immunology / Q000302:isolation & purification*; D002372:Cat-Scratch Disease / Q000175:diagnosis / Q000188:drug therapy* / Q000382:microbiology; D015818:Eye Infections, Bacterial / Q000175:diagnosis / Q000188:drug therapy* / Q000382:microbiology; D005260:Female; D005451:Fluorescein Angiography; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D058449:Intravitreal Injections; D008269:Macular Edema / Q000175:diagnosis / Q000188:drug therapy* / Q000382:microbiology; D000069579:Ranibizumab; D041623:Tomography, Optical Coherence; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors; D014792:Visual Acuity
chemical_list: D020533:Angiogenesis Inhibitors; D000907:Antibodies, Bacterial; D061067:Antibodies, Monoclonal, Humanized; D007074:Immunoglobulin G; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D000069579:Ranibizumab